Key Highlights
- 7.3% above its 52-week low is where Xylem (NYSE:XYL) traded at USD 105.83 on October 16, 2026, per published market data (intraday), implying a low of USD 98.63 by own arithmetic, on a market capitalisation of USD 24.71 billion.
- 42% order growth to USD 3,086 million, with 41% organic, was reported for the second quarter of 2026, yet revenue was USD 2,336 million, up 2% reported and 1% organic, per the company release dated July 28, 2026.
- USD 1.46 adjusted EPS, up 16% from USD 1.26, and a 23.3% adjusted EBITDA margin, up 150 basis points, were reported for the second quarter, while reported EPS was USD 1.11, up 19%.
- USD 5.55 to USD 5.70 of 2026 adjusted EPS guidance was raised from USD 5.35 to USD 5.60, but organic revenue growth guidance was narrowed to 2% to 3% from 2% to 4%, per the July 28, 2026 release.
Orders Versus Revenue Conversion
Xylem (NYSE:XYL) reported second quarter orders of USD 3,086 million, up 42%, against revenue of USD 2,336 million. The order gain came mainly from Water Solutions and Services, where orders rose 151% to USD 1,449 million, while Water Infrastructure orders were flat and down 4% organically. Orders are signed demand that converts to revenue over time, but conversion timing was not quantified in the release. Revenue in Measurement and Control Solutions fell 6% reported and 1% organic, to USD 508 million.
Guidance Detail and Analyst Positioning
The July 28, 2026 release lifted adjusted EPS guidance and narrowed organic growth: revenue of approximately USD 9.2 billion, up approximately 2%, an adjusted EBITDA margin of 23.1% to 23.5% and free cash flow margin of 10.2% to 11.0%, unchanged. After April 28 first quarter results, the original EPS range sat below some analyst models, and UBS downgraded to Hold, per coverage dated April 29, 2026. As of July 28, consensus was Moderate Buy, with 8 Buy and 6 Hold ratings and an average target of USD 153.15, per coverage; Jefferies upgraded to Buy on June 25 with a USD 140 target, and Stifel cut to USD 157 on July 20.
Valuation, Trading and Next Report
The shares opened at USD 120.20 on July 28, 2026, so USD 105.83 is 12.0% lower, own arithmetic. At the USD 5.625 midpoint of adjusted EPS guidance, the shares trade at 18.8 times earnings, own arithmetic. The quarterly dividend of USD 0.43 annualises to USD 1.72, a 1.63% yield, own arithmetic. Intraday volume was 138,276 shares, a relative volume of 0.1x, equal to USD 14.6 million of turnover and 0.06% of market capitalisation, own arithmetic. Xylem is reported to release third quarter results on October 27, 2026; no company filing confirming the date was reviewed.
Where Things Stand
The stock sits 7.3% above its 52-week low because the market is valuing 1% organic revenue growth and a narrowed growth range ahead of 42% order growth that has not yet reached revenue. Xylem (NYSE:XYL) has raised EPS guidance on margin gains, yet the multiple has compressed to 18.8 times guided earnings. The bull case is order conversion and an adjusted EBITDA margin of 23.1% to 23.5%; the bear case is slow organic growth, Measurement and Control weakness and target cuts. The next catalyst is the reported October 27, 2026 third quarter release.






Please wait processing your request...